IL10 and neoplasm: Tregs homed into the tumour microenvironment (Figure 1) secrete immunosuppressive cytokines, such as IL-10 and TGF-β itself, which may contribute to amplify the inhibitory effects of tumour-derived TGF-β on anti-tumour immunity effector cells.